Category: us corporate news

us corporate news

Structure Therapeutics Reports Best-in-Class Oral GLP-1 Weight Loss Results With Aleniglipron in Phase 2 ACCESS II Trial, Prepares for Phase 3 in 2026 1234

Minichart

March 16, 2026

Structure Therapeutics Reports Best-in-Class Oral GLP-1 Agon...

Continue Reading 0

us corporate news

Kinetic Seas and Sagtec Complete Phase 1 of $4M AI Mobility Platform for Malaysia’s Premium Travel Market

Minichart

March 16, 2026

Kinetic Seas Completes Key AI Mobility Milestone in Southeas...

Continue Reading 0

us corporate news

VisionWave Holdings, Inc. Files Form 8-K Announcing Side Letter Agreement and Nasdaq Listing – March 2026

Minichart

March 16, 2026

VisionWave Holdings, Inc. Files Form 8-K: Key Updates for In...

Continue Reading 0

us corporate news

Coya Therapeutics Reports 2025 Financial Results and Advances ALS & FTD Clinical Trials with Strong Cash Position

Minichart

March 16, 2026

Coya Therapeutics, Inc. Provides Corporate Update and Fiscal...

Continue Reading 0

us corporate news

Lifecore Biomedical Targets 12% Revenue CAGR and 25%+ EBITDA Margin by 2029 with CDMO Growth Strategy

Minichart

March 16, 2026

Lifecore Biomedical, Inc. Issues Strategic Update: New Fisca...

Continue Reading 0

us corporate news

Ramaco Resources Announces Q1 2026 Class B Stock Dividend Details and Provides Company Update

Minichart

March 16, 2026

Ramaco Resources Announces Q1 2026 Class B Stock Dividend De...

Continue Reading 0

us corporate news

Aprea Therapeutics Reports 2025 Financial Results and Clinical Progress for APR-1051 WEE1 Inhibitor in Endometrial Cancer

Minichart

March 16, 2026

Aprea Therapeutics Reports Q4 and Full Year 2025 Financials:...

Continue Reading 0

us corporate news

BioMarin Pharmaceutical Inc. 8-K Filing: Company Information, Address, and Stock Details (March 16, 2026)

Minichart

March 16, 2026

BioMarin Pharmaceutical Inc. Announces Discontinuation of Ce...

Continue Reading 0

us corporate news

PTC Completes Sale of Kepware and ThingWorx Businesses to TPG, Announces $375 Million Share Repurchase Program and Updates 2026 Financial Guidance

Minichart

March 16, 2026

PTC Completes Divestiture of Kepware and ThingWorx Businesse...

Continue Reading 0

us corporate news

Relay Therapeutics Reports Promising Phase 3 Data for Zovegalisib + Fulvestrant in PI3Kα-Mutated HR+/HER2- Metastatic Breast Cancer at ESMO TAT 2026 12

Minichart

March 16, 2026

Relay Therapeutics Reports Positive Data for Zovegalisib at ...

Continue Reading 0